Neumora Therapeutics Analyst Ratings
Neumora Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/10/2023 | 114.17% | Stifel | → $26 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年10月10日 | 114.17% | Stifel | →$26 | 开始承保 | →购买 |
What is the target price for Neumora Therapeutics (NMRA)?
Neumora治疗公司(NMRA)的目标价格是多少？
The latest price target for Neumora Therapeutics (NASDAQ: NMRA) was reported by Stifel on October 10, 2023. The analyst firm set a price target for $26.00 expecting NMRA to rise to within 12 months (a possible 114.17% upside). 1 analyst firms have reported ratings in the last year.
Stifel于2023年10月10日报道了Neumora治疗公司(纳斯达克：NMRA)的最新目标价。这家分析公司将目标价定为26美元，预计NMRA将在12个月内升至(可能上涨114.17%)。1家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Neumora Therapeutics (NMRA)?
Neumora治疗公司(NMRA)的最新分析师评级是什么？
The latest analyst rating for Neumora Therapeutics (NASDAQ: NMRA) was provided by Stifel, and Neumora Therapeutics initiated their buy rating.
纽莫拉治疗公司(纳斯达克代码：NMRA)的最新分析师评级是由斯蒂费尔公司提供的，纽莫拉治疗公司启动了他们的买入评级。
When is the next analyst rating going to be posted or updated for Neumora Therapeutics (NMRA)?
Neumora治疗公司(NMRA)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Neumora Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Neumora Therapeutics was filed on October 10, 2023 so you should expect the next rating to be made available sometime around October 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Neumora Treeutics的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Neumora治疗公司的上一次评级是在2023年10月10日提交的，所以你应该预计下一次评级将在2024年10月10日左右的某个时候提供。
Is the Analyst Rating Neumora Therapeutics (NMRA) correct?
分析师对Neumora Treeutics(NMRA)的评级正确吗？
While ratings are subjective and will change, the latest Neumora Therapeutics (NMRA) rating was a initiated with a price target of $0.00 to $26.00. The current price Neumora Therapeutics (NMRA) is trading at is $12.14, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Neumora治疗公司(NMRA)评级是以0.00美元至26.00美元的目标价启动的。Neumora Treateutics(NMRA)目前的交易价格为12.14美元，在分析师的预测范围内。